Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

(1.06)Shares used in computing net loss
per share - basic and diluted

146,280144,033145,730143,525A reconciliation of reported GAAP operating net loss to non-GAAP operating income (loss) excluding non-cash items is provided in the tables that follow (in thousands, unaudited):Quarter ended
December 31, Twelve months ended
December 31, 2011201020112010GAAP operating loss

$ (429,754)$  (10,309)$ (491,459)$  (126,744) Revenue sharing obligation
  note payments on
  net BYETTA sales (1)

(6,088)-(6,088)- Stock-based compensation

9,1948,78832,47236,022 Other non-cash compensation

3,6134,10416,52719,735 Depreciation and amortization

10,50714,89247,37357,335 Amortization of deferred revenue and other credits

(3,141)(1,875)(11,930)(7,500) Net costs to reacquire economic
  interest in exenatide products (1)

431,587-431,587- Restructuring

1,7077,3287,19016,780Non-GAAP operating income (loss)

$  17,625$
22,928$   25,672$   (4,372)Quarter endedDecember 31,Twelve months endedDecember 31,2011201020112010GAAP net loss

$ (461,471)$  (19,183)$ (543,399)$  (152,314) Revenue sharing obligation note payments on  net BYETTA sales (1)

(6,088)-(6,088)- Stock-based compensation

9,1948,78832,47236,022 Other non-cash compensation

3,6134,10416,52719,735 Depreciation and amortization

10,50715,41747,37357,335 Amortization of deferred revenueand other credits

(3,141)(2,400)(11,930)(7,500) Net costs to reacquire economic
interest in exenatide products (1)

431,587-431,587- Restructuring

1,7077,3287,19016,780Interest expense, net

11,7634,65823,9789,002Loss on fair value adjustments

15,751-15,751-Non-GAAP net income (loss)

$  13,422$
8,712$   13,461$   (20,940)Non-GAAP net income (loss) per shareBasic

$ 0.09$ 0.13$ 0.09$  (0.15)Dil
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014   Lincor Inc. ... experience technology to New Jersey ... agreement, CarePoint Health will deploy Lincor,s PatientLINC technology ... Christ Hospital and Hoboken University Medical Center. ... of software solutions to help hospitals reach new ...
(Date:8/19/2014)... 19, 2014 Minimally Invasive Devices Inc. (MID), ... company, announced today that Mitsubishi Corporation has formally agreed ... system in Japan . MID anticipates ... Japan in the second half of ... distributor for Karl Storz GMBH & Co. (endoscopic instruments ...
(Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2
... LLC (Berg) and GNS Healthcare, Inc. (GNS), a subsidiary ... into a joint venture named MAP Biosystems, LLC (MAP) ... critical biomedical research.  MAP will utilize a combination of ... and GNS,s patented supercomputer-driven REFS™ modeling and ...
... March 2, 2011 Accumetrics, Inc., a privately-held developer ... and easy-to-use point-of-care diagnostic system for measuring platelet reactivity ... has signed an agreement with Portola Pharmaceuticals, Inc. to ... use in clinical trials. The VerifyNow System ...
Cached Medicine Technology:Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 2Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 3Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
(Date:8/20/2014)... The finalists are in for the ... trade magazine, will honor the pharmaceutical industry’s most influential ... to outstanding companies, marketers and brand managers representing the ... are proud to announce that we received our biggest ... the number of submissions we received last year,” says ...
(Date:8/20/2014)... 2014 Little Green Pouch today announced ... Green Pouch —to meet growing demand for eco-friendly products ... homemade foods. , “The Real Food movement is ... Crawford. She continues, “Parents want to choose exactly ... things like pesticides and hidden ingredients in commercially prepared ...
(Date:8/20/2014)... 20, 2014 One Call Alert expands its ... of ResCube, a fully-mobile wearable device that connects customers to ... button, 24 hours a day, 365 days a year. , ... cross country. It operates on the T-Mobile nationwide network like ... in to work. , Like with the other One Call ...
(Date:8/20/2014)... Pittsburgh, PA (PRWEB) August 20, 2014 ... to clean the mouth in an optimal manner without ... an inventor from Vacaville, Calif. , The patent-pending DR. ... the tongue and teeth thoroughly. It promotes good oral ... to use two different devices. Convenient, compact, affordable, eco-friendly ...
(Date:8/20/2014)... the car at home and getting to work by walking, ... new study indicates. Researchers looked at thousands of people ... men and 72 percent of women drove to work, 10 ... transit, and 14 percent of men and 17 percent of ... weighed more and had higher levels of body fat than ...
Breaking Medicine News(10 mins):Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:Little Green Pouch Launches New Product to Help Health-conscious Parents Reduce Babies’ Eco-footprint 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3Health News:Want to Stay Slim? Leave the Car at Home 2
... have successfully transplanted the heart of a brain- dead ... whom Chinese traditionally do not consider dead. // ... from a brain-dead patient, the surgery is of great ... of Organ Transplantation of Tongji Hospital under Huazhong University ...
... replacing the traditional paan in Pakistan, its growing import from ... says a media report. ,In Karachi alone, 45,000 kg ... daily. ,The government has permitted imports because ... it is registered as an important import item from countries ...
... occurring infections in children and the onset of Type I ... below the age of 29, with Type 1 diabetes were ... had a number of childhood infections showed a 6 to ... O'Neill, director of care and policy at Diabetes UK, said ...
... University of Bristol have recommended that knee cartilage injuries ... any signs of osteoarthritis progression. ,'The ... only about 12 months and this is the first ... ,The study, 'Maturation of tissue engineered cartilage implanted ...
... warn that thunderstorms resulting from Britain's heatwave could trigger ... long time complaints of asthma sufferers who have claimed ... has revealed that storms sweep up and collect atmospheric ... concentrated in the air close to the ground. ...
... a study published in the Journal of the National ... suffer from premature menopause//. ,Ovarian irradiation and ... most common risk factors associated with early menopausal symptoms. ... with cancer will survive long-term. Survivors have an increased ...
Cached Medicine News:Health News:Engineered Tissue Implants benefited Knee Injured patients 2Health News:Doctors Predict an Asthma Epidemic Triggered by Thunderstorms 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: